chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History Information was reported.     On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea). At the time of the report, DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not provided by the reporter.  Treatment information was not provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 25-Mar-2021 and was forwarded to Moderna on 25-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History Information was reported.     On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea). At the time of the report, DIZZINESS (Dizziness) and DIARRHOEA (Diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not provided by the reporter.  Treatment information was not provided.
Patient having pain 7am 6/8 upon awakening. Sharp, heavy 10/10 left sided chest pain radiated to L arm. Shortness of breath. pain worse with inspiration, no positional changes. Similar to previous myocarditis episode in 2019 (thought to be 2/2 virus as had fevers, fully resolved). No recent URI, last sick 1 year ago, no covid per knowledge. Had COVID vaccine week prior without side effects. Presented to hospital. Initial troponin 0.819> 4.43. CK-MB 42.8, CK 471. BMP, CBC, CRP within normal limits. ECG non ischemic however mild j-point elevation in anterior leads consistent with myocarditis. POCT echo normal. Patient admitted for IVIG, steroids, viral panel and monitoring.
Nausea about 2 hours after getting shot; This is a spontaneous report from a non-contactable consumer (patient himself).  A 30-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Batch/Lot number: EN6202, Expiration Date was not reported), via an unspecified route of administration, administered in left arm on 07Mar2021 11:30 (at the age of 30-year-old) as 1st dose, single dose for covid-19 immunisation. Medical history included depression. Concomitant medication included cannabis (CANNABIS). Other medication taken in two weeks included Cannabis. No other vaccine taken in four weeks. On 07Mar2021 01:45 AM, the patient experienced Nausea about 2 hours after getting shot. Patient ate beforehand and used a typical amount of cannabis after got home. Was about 80% of the way to barfing.  Therapeutic measures were taken as a result of nausea about 2 hours after getting shot. AE treatment included I popped two Peptos, a Tum, and a meclizine. Patient had not been diagnosed with COVID-19 prior to vaccination and had not tested positive since the vaccination. The outcome of the event was reported as resolved.  No follow-up attempts are possible. No further information in expected.
Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms; Stuffy, runny nose; Severe stiffness in her elbows and knees; Did not experience pain like this before; Pain in the joints everywhere in her body/Side pain and wrist pain last week; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms), RHINORRHOEA (Stuffy, runny nose), JOINT STIFFNESS (Severe stiffness in her elbows and knees), PAIN (Did not experience pain like this before) and ARTHRALGIA (Pain in the joints everywhere in her body/Side pain and wrist pain last week) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms), RHINORRHOEA (Stuffy, runny nose), JOINT STIFFNESS (Severe stiffness in her elbows and knees), PAIN (Did not experience pain like this before) and ARTHRALGIA (Pain in the joints everywhere in her body/Side pain and wrist pain last week). At the time of the report, MOBILITY DECREASED (Hard a hard time sitting in a chair and using the bathroom/ Can't lift her arms), RHINORRHOEA (Stuffy, runny nose), JOINT STIFFNESS (Severe stiffness in her elbows and knees), PAIN (Did not experience pain like this before) and ARTHRALGIA (Pain in the joints everywhere in her body/Side pain and wrist pain last week) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was reported by reporter.   This case was linked to MOD-2021-228387 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: follow-up was received and contains no significant information
3x3 in redness around injection site, soreness reported with movement. Advised by MD to apply warm packs and monitor.
Approximately 24 hours after administration of vaccine, the patient developed symptoms consistent with a left sided Bell's Palsy.  This examiner did not see the patient on the day of vaccination but 5 days later when the patient presented to care.
Patient was vaccinated on Friday 6/2/23 4:11 pm. Next morning, Saturday, had joint pain, red and warm blotches that travels down elbow. This continued to worsen still by Monday. Finally patient took a Benadry night of Monday which did not seem to help and arm still swollen some more. I advised her to seek medical attention since she may require prednisone to treat this allergic reaction. She said she will do.
Broke out with a rash 4 days later started seizing. Temp was 101 on 12/8/2011.
pt recvd vax; did not develop chicken pox;a male relative in contact w/ pt on 1jul95 & subsequently devel chicken pox on 22jul95;there was no exposure to chicken pox;vaccinee father also devel chicken pox;
Swollen red arm at injection site, headache, body aches, stomach discomfort. 7 days now after injection still slightly red and itching. Spoke with my doctor and she suggests not getting the second injection. Please advise.
Superficial venous thrombosis in right leg resulting in Pulmonary Embolism.
youth given vaccine on Thursday May 2nd, youth began running a fever Thursday night that lasted through Saturday, temperature reaching 103.2 degrees. On Monday May 6th youth's skin is peeling badly just like a sunburn but youth has not been in the sun without his shirt on. Youth has cellulitis/abscess noted today to left underarm.
vomiting; chills; wasn't feeling well; This is a spontaneous report from a contactable consumer. A 37-year-old male patient (reporter's son) received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration, on Mar2021, at 3pm as a single dose, for COVID-19 immunisation. Medical history included COVID-19 infection, in June or July 2020. It was reported that the patient had a very severe case of the COVID-19, which lasted for 2 weeks and the patient was very ill. The patient's concomitant medications were not reported. In Mar2021, the patient experienced vomiting, chills and wasn't feeling well. The patient had told the reporter that he was going to go to sleep and see if he feels better. The reported stated that the patient moved away a few weeks ago so he didn't have a doctor there. The clinical outcome of the events vomiting, chills, wasn't feeling well was unknown.   Follow-up attempts are completed. No further information is expected.
My armpit started becoming sore the following day and now my lymph nodes are swollen and it hurts to have my arm down as it is hitting the swollen lymph nodes. I had zero issues with the first shot in the series.
Started feeling feverish and had a cough on 12/10/2022. Took a Home COVID-19 test and tested positive on 12/12/2023. Doctor prescribed Tessalon Perles. Tested negative for COVID- 19 on 12/27/2022.
gave 4 doses that were expired; vial was initially stored in the refrigerator on 12Jul2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave 4 doses that were expired) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 12Jul2022) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046L21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 12Jul2022). On 13-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave 4 doses that were expired). At the time of the report, EXPIRED PRODUCT ADMINISTERED (gave 4 doses that were expired) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 12Jul2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.              The patient was administered with booster dose. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter.
Approximately 28 hours after my #2 booster vaccine I stood up, felt tenderness on my left hip and began limping as I walked.  It wasn't particularly painful as I sat but the soreness was very apparent.  It was as if the soreness from the injection sight on my left arm traveled down to my left hip.  I took 3 Ibuprofen on day #3 with no relief.  On day #4 I again took 3 Ibuprofen and some of the soreness was alleviated but not completely.
Early morning stiffness; Early morning joint stiffness; Feeling hot; Fatigue; Psoriasis flare-up; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Psoriasis flare-up), MUSCULOSKELETAL STIFFNESS (Early morning stiffness), JOINT STIFFNESS (Early morning joint stiffness), FEELING HOT (Feeling hot) and FATIGUE (Fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In December 2021, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to Citrate free. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to Citrate free. In November 2021, the patient experienced PSORIASIS (Psoriasis flare-up). On 07-Dec-2021, the patient experienced FEELING HOT (Feeling hot) and FATIGUE (Fatigue). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Early morning stiffness) and JOINT STIFFNESS (Early morning joint stiffness). In 2021, PSORIASIS (Psoriasis flare-up) had resolved. On 11-Dec-2021, FEELING HOT (Feeling hot) and FATIGUE (Fatigue) had resolved. At the time of the report, MUSCULOSKELETAL STIFFNESS (Early morning stiffness) and JOINT STIFFNESS (Early morning joint stiffness) outcome was unknown. Not Provided          Causality for HUMIRA(ADALIMUMAB) Solution for injection in pre-filled: The reporter's causality for the event(s) of PSORIASIS BREAKOUT/IN HEAD/SMALL OF BACK AND ARMS, PSORIASIS. BREAKOUT, STIFFNESS IN HANDS AND JOINTS IN MORNING unknown onset, STIFFNESS IN HANDS AND JOINTS IN MORNING. unknown onset, AFTER THIRD COVID-19 VACCINE FATIGUED and AFTER THIRD COVID-19 VACCINE HOT was not provided. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No information on concomitant medication were reported. No treatment details were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
A report was received from a health care professional on 12 November 2003, concerning an unspecified number (approximately 12-24) of vaccinees who inadvertently received 1 ml Fluvirin on an unspecified date. On an unspecified date, an unspecified number of vaccinees inadvertently received 1 ml Fluvirin intramuscularly. The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment.  Update 1, 02 January 2004. A follow up report was received from a health care professional concerning a 22 vaccinees who inadvertently received 1ml Fluvirin on 13 November 2003. No adverse effects were experienced at the time of reporting. No follow up pending.
Two shingles episodes, went down nerve 3 inches; itching spot; burning spot; This non-serious case was reported by a nurse via call center representative and described the occurrence of shingles in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (prior shingles outbreaks).   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular, left deltoid). On an unknown date, 1 week after receiving Shingrix, [the patient experienced shingles (Verbatim: Two shingles episodes, went down nerve 3 inches), pruritus (Verbatim: itching spot) and burning sensation (Verbatim: burning spot).         The patient was treated with acyclovir (Zovirax) and acyclovir (Zovirax Ointment). The outcome of the shingles, pruritus and burning sensation were recovered/resolved.   It was unknown if the reporter considered the shingles, pruritus and burning sensation to be related to Shingrix.     It was unknown if the company considered the shingles, pruritus and burning sensation to be related to Shingrix.   Additional Information: GSK Receipt Date: 06-MAR-2023 The reporter was the patient and she was a (retired) nurse.  She reported that she had Shingrix shot on an unknown date around January 2023 or sometime in late Jan/Feb 2023.  She did not have the exact date with her at the time of the call. She did not have the lot number but did provide her pharmacy's contact information which would have that information on record.  About a week later, developed shingles on her left buttock that went down her nerve for about 3 inches. She was treated with Zovirax pills and Zovirax ointment and it went away.  Two weeks later the shingles episode came back again.  She indicated that it was not a full blown case it was just a spot that itched and burned.  These events was resolved.  She had not received Shingrix shot 2. She was a nurse transferred her to GSK medical information.  It appears she called back and spoke to a different GSK-MI agent who may not have been aware that The reporter was already filing a report.  The reporter was consented to follow up. This case has been linked with the case US2023035551, reported by the same reporter.; Sender's Comments:  US-GSK-US2023035551:Same reporter
Sore; pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore; pain at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore; pain at the injection site). At the time of the report, VACCINATION SITE PAIN (Sore; pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs and treatment medications were reported.   This case was linked to MOD-2021-125065, MOD-2021-125026, MOD-2021-124992, MOD-2021-124815 (Patient Link).
Arm ached; Red rash; Itching; Feels like she received the shot today; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm ached), RASH ERYTHEMATOUS (Red rash), PRURITUS (Itching) and ADVERSE DRUG REACTION (Feels like she received the shot today) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LOSARTAN and LEVOTHYROXINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm ached), RASH ERYTHEMATOUS (Red rash), PRURITUS (Itching) and ADVERSE DRUG REACTION (Feels like she received the shot today). At the time of the report, PAIN IN EXTREMITY (Arm ached), RASH ERYTHEMATOUS (Red rash), PRURITUS (Itching) and ADVERSE DRUG REACTION (Feels like she received the shot today) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment information was not provided.
Left arm pain from elbow to shoulder. Left sided chest pain that radiated to mid sternum. Shortness of Breath. Pain more localized on the left side of chest and into rib cage area. Pain level was severe. Went into the emergency room and received pain medication, Ekg, Blood work and Chest Xray.
Patient received a third dose in error; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) (batch number 5H29X, expiry date unknown) for prophylaxis.   Previously administered products included Shingrix (received first dose on 12th October 2021) and Shingrix (received second dose on 7th January2022).   On 8th July 2022, the patient received the 3rd dose of Shingrix. On 8th July 2022, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   Additional Information: GSK receipt date: 13-JUL-2022 Reporter's comment: The nurse reported that the patient received his 3rd dose of Shingrix in error. The nurse also asked if there was any action that need to be taken. The reporter consented to follow-up. Additional supportive information: The patient had received 3rd dose of Shingrix in error, which led to extra dose administered.
Pt developed pain in the lt arm at the inject site /p receiving TD. Pain radiated from arm to back of the 2nd & 3rd fingers of the hand. Paresthesia back of hand. DX mononeuritis 2nd to TD vacc.
This spontaneous report as received from a pharmacy technician refers to three patients of unknown age and gender. On an unknown date the patients were vaccinated with ZOSTAVAX, 19400 PFU, 0.65 ml, subcutaneously for doctor recommendation. Healthcare worker reported that three unspecified patient developed redness and itchiness at the injection site after receiving ZOSTAVAX (2-3 days after receiving ZOSTAVAX). She thinks that the all three of the patients received lot # H021291 and expiration February 2014 of the ZOSTAVAX. Healthcare worker reported that the unspecified patients were instructed by pharmacist to apply an ice pack to the injection site. On an unspecified date, the patients recovered from events. Additional information has been requested.
Client came in for 3rd HPV injection and reported to have smooth hands.  Stated she has had warts on hands for as long as she remembers and since start of HPV injections, hands are smooth.  Mother stated she had active genital warts when she vaginally gave birth to patient.  Mother swears the vaccine helped her daughter's warts.
1) within 1 week of having received 2nd dose of Moderna vaccine I developed a low grade fever and was quite lethargic soon after awakening;  (May/15 - May/21); 2) I started feeling less lethargic but something was not right; 3) on Sunday 5/23 - I awoke to a fever and night sweats; this would continue every night I tried to sleep from Sunday 5/23  - Friday June/04. 4) I reported this to my primary care physician and a blood draw appt was made for May/27 and face-face annual check-up on June/1st. 5)  Several of my blood marker results were concerning and I was asked to repeat blood test and include Urine test. I am being told that I have markers for potential Multiple Myeloma.
Immediately after the shot I did develop some pain in the shoulder and a little tingling in the left hand. This was not a concern to me . I figured that was normal. Within six hours I started to develop tingling in my feet which moved up to my legs through the night and over the course of the next couple days. I experienced tingling, twitching, mild tremors in my quads. Sunday morning I had two bouts of chills. The tingling and the twitching in my feet and legs were bothersome: Ibuprofen and Tylenol seemed to help.. Last night I decided not to take any medicine to see if I continue to have this response. I took melatonin and while in bed I felt that my symptoms were improving. I woke up with minimal neurological involvement  (still some twitching and tingling , though not painful,  but noticeable. I believe I?m improving.  I did make an appointment virtually with the Ireland Army health clinic today at 11 AM. My doctor was not available so I was lined up with another Primary Care Provider. He told me he believes this was an adverse reaction to the vaccine and since I?m starting to see some improvement he told me to only go back if I started to get worse. He felt that I would continue to improve over time.
Patient returned after 15 minute observation with complaints of "chest pain"; denies pain radiating towards arm or having difficulty breathing; pain rated 3/10 on p.ain scale. RN and LPN assess vitals, provide water, extend observation time to 30 minutes, and assure pt sits upright. Vitals: B/P: 102/64; HR: 68; O2 Sats: 97% on room air; RR: 16; anterior lungs clear bilaterally. Pt spoke in full complete sentences without difficulty RN and LPN educated parent on high alert symptoms and when to call 911 or pediatrician. Pt vitals after 30 minute observation: BP: 110/72; HR: 72; O2 Sats: 98% on room air; RR: 16. Pt spoke clearly without difficulty and was alert and oriented to person, place, and time.
pt recv vax 1995 & devel what was dx as herpes zoster;pt had two major patches;reporter felt that the upper patch was definitely zoster & that the lower patch (4-5 clusters) may not have been zoster;